The Alliance of Specialty Medicine submitted a letter to Senate Finance Committee Chairman Grassley (R-IA) and Ranking Member Wyden (D-OR) to express deep concern with Section 102 of the Prescription Drug Pricing Reduction Act, which is being considered by the committee on July 25th. Section 102 would reduce the availability of copay assistance for patients and lead to reductions in physician reimbursements which are used to cover the cost and storage of physician administered Part B drugs. This could lead to decreased access for patients or alternatively shift patients, especially those in rural areas, to a more expensive hospital setting to receive their drugs. The letter can be accessed by clicking the link below.
Alliance Letter to Senate Finance on Sect. 102 of PDPRA 2019
